

25 years of bigger leaps
For 25 years, Flagship Pioneering has endeavored to make the impossible possible, pushing the boundaries of knowledge to pioneer a better future for people and the planet.
We are celebrating not just the breakthroughs we’ve achieved, but the people who make them happen. Through these stories, we share the passion and purpose that shape our culture of fearless exploration and discovery.

Pioneering Partnerships

Mirai Bio Announces Partnership with Thermo Fisher Scientific to Accelerate Development of Genetic Medicines

Repertoire® Immune Medicines Enters into Collaboration and License Agreement with Genentech for the Development of T cell-Targeted Therapies for an Autoimmune Disease

Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease

Valo Health and Novo Nordisk Expand Collaboration to Discover and Develop Novel Treatments for Cardiometabolic Diseases

Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer

Vesalius Announces Multi-Target Strategic Alliance with GSK to Develop Breakthrough Treatments for People Afflicted with Parkinson’s Disease
Our Companies
- Moderna Founded: 2010
- Tessera Therapeutics Founded: 2018
- Generate:Biomedicines Founded: 2018
- Inari Agriculture Founded: 2016
- Quotient Therapeutics Founded: 2022
- Lila Sciences Founded: 2023
Latest News
- Flagship Pioneering Unveils Terrana Biosciences to Deliver Adaptive, Targeted Agricultural Solutions through a Novel RNA Technology Platform 07.01.2025
- ProFound Therapeutics Announces Multi-Year Strategic Collaboration with Novartis to Discover and Develop Novel Therapeutics for Cardiovascular Disease 06.26.2025
- Mirai Bio Announces Partnership with Thermo Fisher Scientific to Accelerate Development of Genetic Medicines 05.20.2025
- Ted Myles Joins Cellarity as Chief Executive Officer 05.12.2025
- Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development 05.07.2025
- Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics 04.29.2025
Employee Spotlight

Off the Clock with Flagship Employees

Life Illustrated: Lovisa Afzelius
Companies founded
100+